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Introduction: Amyotrophic lateral sclerosis (ALS) might not only be circumscribed to the
motor system but also involves other neuronal systems including sensory abnormalities.
In line with this notion, we aimed to assess the pathophysiology of sensory disturbances
in the SOD1G93A mouse model of ALS, focusing on the satellite glial cells (SGCs) at the
dorsal root ganglion (DRG) as a new potential target of the disease.
Material andMethods: The presence of sensory disturbances was evaluated using von
Frey, hot plate, and hot water tail immersion tests at 75 days old, which represented the
motor-pre-symptomatic stage. Cell biology analysis was performed at 75 and 95 days
old and included conventional histology, immunofluorescence, and electron microscopy
of sensory neuron-SGC unit dissociates as a well as western blotting from DRG lysates.
Results: At 75 days old, von Frey and hot plate tests demonstrated clear thermoalgesic
disturbances in ALS transgenic mice. Histological studies of the SN-SGC units revealed
abnormal SOD1 accumulation, which was associated with nitro-oxidative stress and
biogenesis of lipid droplets in SGCs. Interestingly, these alterations led to a progressive
lysosomal storage disorder and occasionally vacuolar degeneration in SGCs.
Conclusions: SGCs emerge as a primary pathophysiological target in the SOD1
transgenic murine model of ALS, clearly reinforcing the pathogenic role of glial cells
in motor neuron disease. Presymptomatic alterations of SGCs, might not only be
responsible of sensory disturbances in ALS, but due to spinal cord sensory-motor circuits
could also contribute to anterior horn motor disturbances.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease affecting
motor neurons (MNs) with an annual incidence that ranges from 1 to 3 cases per 100,000
individuals (Logroscino et al., 2010; Riancho et al., 2016). The pathogenesis of ALS has not yet
been completely elucidated. A small percentage (20%) of cases have a familial origin (fALS)
that is related to mutations in specific causative genes such as SOD1, CR9ORF72, TARDBP, and
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FUS (for a review, see Zufiría et al., 2016). In contrast, the
vast majority of cases are thought to be sporadic (sALS)
and caused by interactions between genes and environmental
conditions, leading to disease onset in genetically predisposed
individuals (Riancho et al., 2018). Clinically, ALS is characterized
by the progressive degeneration of both upper and lower MNs
typically results in progressive muscle wasting and usually lead
to death within 3 years after symptom onset (Amato and Russell,
2008). Since its description, ALS has been classically considered
as a “motor system-circumscribed disease”; however, other
clinical manifestations, including autonomic disorders, cognitive
impairment and sensory disturbances, have been reported in
patients with ALS. Regarding the latter, several experimental
and clinical studies support some degree of sensory system
impairment in individuals with ALS (Chiò et al., 2017; Riancho
et al., 2020b).
Concerning preclinical studies, most evidence has been
generated using the murine SOD1G93A model. First, Guo et al.
(2009) used this model to study the sensory system at several
levels, including the dorsal roots, dorsal root ganglia (DRG),
and posterior column tracts. Interestingly, the authors observed
a loss of axons, cellular alterations, and demyelination. Shortly
thereafter, Sábado et al. (2014) reported demyelination and a
loss of axons in the posterior roots as well as loss of neurons
and SOD1 accumulation in the DRG of this murine model.
Consistent with this finding, researchers have postulated that
sensory disorders in the SOD1 mutant murine model might be
associated with the accumulation of a neurotoxic splice variant
of peripherin (Sassone et al., 2016). Within this model, some
investigators have noted that proprioceptive sensory neurons are
particularly susceptible to pathology (Sábado et al., 2014; Seki
et al., 2019). In addition, according to Vaughan et al. (2018)
cultured sensory neurons harboring mutations in either TDP43
and SOD1 exhibit lower growth rates, reduced neurite branch
generation, and an increased susceptibility to cellular stress,
thus suggesting important roles for this neuronal population in
ALS-related pathogenesis.
The DRG contains the cell bodies of neurons that transmit
the sensory information (proprioceptive, light touch, vibration,
thermoceptive, and nociceptive information) from the periphery
to the central nervous system (CNS) through the dorsal and
anterolateral tracts of the spinal cord (Haberberger et al., 2019).
In addition to controlling sensory information, proprioceptive
sensory neurons are key modulators of motor behavior that
integrate the sensory and motor systems into the CNS.
Interestingly, sensory neurons have been recently suggested as
ALS targets in a Drosophila model of MN disease (Held et al.,
2019).
Classically, rodent DRG neurons are classified into three
main morphological based on their size and the distribution
of their organelles: A (large), B (medium size), and C (small
dark) (Pena et al., 2001). Type A neurons have thick myelinated
fibers and are mainly mechanoreceptive (proprioceptive). Type B
neurons exhibit thin myelinated fibers and are mechanoreceptive
and nociceptive. Finally, non-myelinated, slow conducting, type
C neurons are mainly involved in thermo- and nociception
(Wotherspoon and Priestley, 1999; Hunt and Koltzenburg, 2005;
Berta et al., 2017). Each sensory neuron (SN) is wrapped by the
cell bodies and laminar processes of several satellite glial cells
(SGCs), forming a morphological, and functional unit (SN-SGC
unit) (Pannese, 1981; Hanani, 2005). SGCs play an important role
in regulating sensory neuron function, particularly in controlling
the neuronal microenvironment (Hanani, 2005; Haberberger
et al., 2019).
Although the selective cell death of MNs is a key feature
of ALS, other tissues, and organs may be responsible for the
clinical manifestations of the disease (for a review, see Zufiría
et al., 2016). In fact, as shown in our recent study, that dermal
fibroblasts from patients with ALS recapitulate alterations typical
of ALS motor neurons and exhibit an abnormal DNA-damage
response (Riancho et al., 2020a). Therefore, the DRG in the PNS
might contribute not only to the subtle sensory manifestations
of patients with ALS but also to MN degeneration by impairing
sensory-motor spinal networks.
The aim of this study is to determine the cellular basis of
the sensory system impairment in SN-SGC units in SOD1G93A
mice. To date, the SOD1 transgenic mouse has been the most
extensively employed animal model for preclinical investigations
of ALS. High-copy SOD1G93A transgenic mice recapitulate
an important proportion of the pathophysiological features
of human ALS, including progressive MN degeneration and
neuromuscular function loss as well as a reduced lifespan
(Gurney et al., 1994). Although this mouse model is based on
a familial form of the disease, several authors have highlighted
its translational value in studies of sALS (Bosco et al., 2010).
The potential contribution of SGCs to the sensory component of
ALS at both, late presymptomatic (75 days old) (Riancho et al.,
2015) and symptomatic (95 days old) stages should receive special
attention. Based on our results thermonociceptive and fine touch
dysfunction accompanied motor alterations in the SOD1G93A
mouse model of ALS. Sensory disturbances correlated with high
expression of mutant SOD1 in SGCs, which appeared to increase
lipid peroxidation and an aberrant storage of lysosome-related
structures, preferentially in SGCs belonging to type B andC units.
METHODS
Animals
The transgenic mice used were B6SJL-Tg (SOD1G93A 1Gur/J
(SOD1G93A) obtained from The Jackson Laboratory (Bar Harbor,
ME, USA) and maintained at the Animal Service of the
University of Cantabria. The colony was maintained by mating
heterozygous transgenic males with B6SJLF1/J hybrid females.
Real time quantitative PCR of DNA obtained from tail tissue
was used for genotyping, with specific primers detecting
human SOD1 and the housekeeping mouse gene ApoB. Primer
sequences were: SOD1: GGG AAG CTG TTG TCC CAA G
and CAA GGG GAG GTA AAA GAG AGC; ApoB: TCA
CCA GTC ATT TCT GCC TTT G and GGG AAG CTG TTG
TCC CAA G. Transgenic mice and control littermates were
housed under controlled temperature and humidity, with a
12-h light/dark cycle and free access to water and food. The
experimental protocol was approved by the Ethics Committee of
the University of Cantabria following the Spanish legislation. All
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animal experiments were carried out in accordance with the EU
Directive 2010/63/EU.
Male animals were distributed into four groups: two wild-
type mice (75 and 95 days old) and two SOD1G93A mice (75
and 95 days old). In SOD1G93A mice these age stages correspond
to the presymptomatic and symptomatic stages of the disease in
this murine model. Globally, sensory tests included 23 transgenic
SOD1 and 23 wildtype mice, respectively. For light microscopy
and immunofluorescence 16 control and 16 SOD1 animals were
used. Finally, biochemical analysis was performed in 3 transgenic
and 3 wild type mice, respectively.
Rotarod and Sensory Tests
For investigating the presence of subjacent sensory disorders
and in order to not be biased by motor symptomatology, tests
were performed on day 75 of life. Globally 23 wild-type and 23
transgenic mice were used. Before assessing sensory disturbances
mice weight and rotarod performance and were evaluated as
previously described (Riancho et al., 2015). Sensory tests included
von Frey hair test, hot water tail immersion test, and hot plate test.
These tests assess nociception induced by both, mechanical and
thermal stimuli.
For von Frey test, mice were placed into the corresponding
testing area and left there for 20min. Once habituated,
mechanical stimuli with von Frey filaments (Semmes Weinstein
von Frey Aesthesiometer for Touch Assessment, Stoelting Co,
Illinois EEUU)were applied on the forelimb of each animal. Limb
shaking or limb licking, were considered as positive responses.
Nociceptive threshold was then determined as the force evoking
a 50 percent of positive responses.
The hot water tail immersion test evaluated the latency of the
tail flick reaction in mice after immersing their tails in a constant
temperature bath. Three centimeters of mice tail were submerged
in hot water at 45, 47, and 49◦C, respectively. A cut off point of
60 s was stablished in order to avoid tissue damage. For hot plate
test, mice were place into 2 metallic cylinders which had been
previously heated up to 50 and 52◦C. Then the latency until the
animal exhibited a positive response, considered as limb shaking,
limb licking, or jumping, was measured. A cut off point of 120 s




To study histological changes, 8 mice of each group (SOD1
and control mice) were euthanized on days 75 and 95,
respectively, and their dorsal root ganglia (DRG) processed for
light microscopy and immunofluorescence. After deep anesthesia
with pentobarbital (50 mg/kg) mice were perfused with 3.7%
paraformaldehyde in PBS (pH 7.4) for 15min. DRG were
dissected and post-fixed for 2 h. Small tissue fragments were
processed for mechanical dissociation of SN-SGC units following
the procedure of Pena et al. (2001). Briefly, DRG fragments
were transferred to a drop of PBS on a siliconized slide. Then,
a coverslip was applied on top of the slide and the tissue was
squashed by percussion with a histologic needle to dissociate
neuronal cell bodies. The preparation was then frozen in dry
ice, and the coverslip removed using a razor blade. Using
this procedure most SN-SGC units remained adhered to the
slide. Cell samples were processed in 96% ethanol at 4◦C for
10min and rehydrated progressively in 70% ethanol and PBS.
Some preparations were stained with propidium iodide (PI), a
fluorescent staining of nucleic acids. For immunofluorescence,
squash preparations were sequentially treated with 0.5% Triton
X-100 in PBS, 0.1M glycine in PBS containing 1% bovine serum
albumin and incubated with the primary antibody overnight
at 4◦C. Then, the sections were incubated with the specific
secondary antibody conjugated with FITC or Cy3 and mounted
with Vectashield (Vector USA). Confocal images were obtained
with a LSM510 (Zeiss, Germany) laser confocal microscope using
the 63x oil (1.4 NA) objective. In order to avoid overlapping
signals, images were obtained by sequential excitation at 488
and 543 nm, to detect FITC and Cy3, respectively. Images were
processed using Photoshop software.
To determine the relative nuclear and cytoplasmic levels of
SOD1 in both sensory neurons and SGCs in wild-type and
SOD1G93A mice confocal images were recorded by using a 63x oil
(1.4 NA) objective and the same confocal settings at resolution
of 1,024 × 1,024 pixels. Images were background corrected by
reference regions outside the tissue and fluorescence intensities
were estimated by using the ImageJ software (NIH, Bethesda,
Maryland, USA; http://rsb.info.nih.gov/ij/).We use three animals
per experimental group and at least 35 neurons per animal
were sampled.
The following primary antibodies were used. Goat
polyclonal antibody anti-cathepsin D (dilution 1:100;
Santa Cruz Biotechnology, USA) and rabbit polyclonal
antibodies anti-SOD1 (dilution 1:100; Enzo Life Sciences,
Switzerland) and anti-ubiquitin-protein conjugates (dilution
1:50; Biomol International).
In situ Determination of Lipid Peroxidation
For the determination of lipid peroxides squash preparations
of DRG fixed with 3.7% paraformaldehyde in buffer phosphate
0.12M were air dried, washed in PBS and incubated with the
probe C11-BODIPY581/591 or BODIPY493/503 (Molecular Probes,
USA) at the concentration of 1µg/mL for 30min at 37◦C
(Liu et al., 2015). Then, the samples were washed in PBS and
mounted with the antifading agent Vectashield-DAPI (Vector
Laboratories, USA). Images were acquired immediately with a
Zeiss LSM 510 microscope.
Electron Microscopy
For electron microscopy, wild-type and SOD1G93A mice were
deeply anesthetized and perfused with 1% glutaraldehyde and 1%
paraformaldehyde in 0.12M phosphate buffer. Tissue samples of
the DRG were postfixed with 2% osmium tetroxide dehydrated
in increased concentrations of ethanol and embedded in Araldite
(Durcupan, Fluka, Switzerland). Semithin sections (1 mµ thick)
were stained with toluidine blue for the light microscopy
examination of the DRG. Ultrathin sections mounted in copper
grids were stained with uranyl acetate and lead citrate and
examinedwith a Jeol 2011 electronmicroscope operated at 80 kV.
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Western Blotting
For Western blot (WB) analysis, DRG were homogenized
in a lysis buffer (0.1 mol/L NaCl, 0.01 mol/L Tris-HCl, pH
7.5, 1 mmol/L EDTA, and 1 µg 7Ml aprotinin) and the
homogenates were centrifuged. Overall, 3 SOD1 and 3 control
mice were used, respectively. The protein in the supernatants
were subjected to SDS-PAGE electrophoresis and afterwards
transferred to polyvinylidene difluoride membranes, stained with
antibodies and visualized with the Odyssey system (LI-COR
Biotechnology). Alpha-Tubulin was used as protein loading
control. The antibodies used were rabbit polyclonal anti-
SOD1 (dilution 1:1,000; Enzo, Life Sciences, Switzerland), goat
polyclonal antibody anti-cathepsin D (dilution 1:2,000; Santa
Cruz Biotechnology, USA) and mouse monoclonal anti-Tubulin
(dilution 1:000; Abcam, Cambridge, USA). ImageJ software (U.S.
National Institutes of Health, Bethesda, Maryland, USA) was
used to quantify the density and size of the blots.
Statistical Analysis
The significance of the differences in weight differences was
tested by unpaired Students’t-test, while non-parametric Mann-
Whitney U-test was used to compare sensory test scores of
wild-type and SOD1G93A mice.
FIGURE 1 | Sensitive pathology in SOD1G93A mice. (A) Rotarod test showed a progressive neuromuscular deterioration in SOD1 transgenic mice from day 95
onwards. (B) ALS mice exhibited a significant lower weight during the whole experimental period (Students’t-test, *p < 0.05; **p < 0.005). (C) Globally, von Frey test
evidenced a lower non-significant tactile threshold in the control group in comparison to SOD1 transgenic mice (1.65 vs. 2.14). Of note, 3 ALS transgenic mice
showed a markedly higher tactile threshold, thus suggesting some degree of tactile disturbance. (D) When evaluating the proportion of positive responses depending
on the filament force, a clear significant delayed response was evidenced in SOD1 transgenic mice from 1g upwards (Students’t-test, *p < 0.05; **p < 0.005; ***p <
0.0005). (E,F) Hot plate test evidenced a significant delayed response in ALS transgenic mice when compared to control mice at both 50 Celsius degrees (E) 49 vs.
74 s; Students’t-test, *p < 0.05) and 52 Celsius degrees (F) (10 vs. 21 s; Students’t-test, **p < 0.005).
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FIGURE 2 | Expression of SOD1 in SN-SGC units from control and SOD1G93 mice. (A) Western blotting of SOD1 expression in DRG lysates from control and
SOD1G93A mice. Note the high levels of SOD1G93A expression found in SOD1 transgenic mice. α-tubulin was used as load control. (B) Representative example of a
typical SN-SGC unit in a control DRG. GSCs appear colored in pale yellow. (C,D) Densitometric analysis of SOD1 expression in the nucleus and cytoplasm of SGCs
and sensory neurons at 75 and 95 days of age. (E–L) Immunodetection of SOD1 in control and SOD1G93 SN-SGC functional units at 75 (E–H) and 95 (I–L) days of
age. (E,I) Images of control SN-SGC units showing low levels of SOD1 expression in the nucleus and cytoplasm from both sensory neuron and SGCs (arrows).
(F–H,G–L) Representative examples of types (A–C) SN-SGC units from SOD1G93A at 75 and 95 days of age. Note the high levels of cytoplasmic SOD1 in SGCs and
the moderate expression of SOD1 in sensory neurons. (M) A SN-SGC unit of a SOD1G93 mouse immunolabeled for SOD1 and counterstained with PI illustrating the
(Continued)
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FIGURE 2 | high concentration of SOD1 in the glial cytoplasm and its aggregation in cytoplasmic inclusions (arrows). Note the low expression of SOD1 in the neuronal
cytoplasm and the well-preserved Nissl substance and prominent nucleolus counterstained with PI. (N,O) Detail of SGC cytoplasm from SODG93A mice showing areas
with different SOD1 concentration and the presence of inclusions highly enriched in SOD1. (P) Immunodetection of ubiquitin-protein (Ub-prot) conjugates forming
cytoplasmic aggregates in a SGC from a SOD1G93 mouse. The cell nucleus of the SGC appears unstained. Scale bar: (B) and (E–L): 10µm. (M–P): 5µm. Student
t-test in (C,D) p < 0.001, ***p < 0.001.
RESULTS
Presymptomatic SOD1 Transgenic Mice
Exhibit Sensory Disturbances at 75 Days of
Age
The presence of sensory alterations was evaluated in 75-
day-old mice to avoid any motor-induced bias. Before the
assessment, all mice performed the rotarod test to exclude any
subjacent neuromuscular disorder. At that age, no differences in
rotarod performance were observed between wild-type (hereafter
referred to as control) and transgenic mice. As expected, a
progressive worsening in rotarod performance was observed
beginning at day 90 of life (Figure 1A). Consistent with our
previous studies (Riancho et al., 2015), ALS transgenic mice
exhibited a significantly lower weight than controls (Figure 1B).
The mechanical nociceptive threshold von Frey hair test
evaluated the sensation of pain. This test is based on the principle
that a compressed elastic column will buckle elastically at a
specific constant force. The filaments (hairs) are used to provide
a range of forces to the mouse forelimb and identify the force
to which the animal reacts because it causes a painful sensation.
Globally, the results of the von Frey test revealed a lower but non-
significant tactile threshold (force at which the animal moved off
its limb at least 50% of the time) in the control group than in
ALS transgenic mice (mean force, 1.6 ± 0.21 vs. 2.1 ± 0.09, p
= 0.0634, Figure 1C). Notably, 3 ALS transgenic mice exhibited
markedly higher tactile thresholds, thus suggesting some degree
of tactile disturbance. Although no significant differences were
noted in the global threshold analysis, clear and significant delays
were observed when forces of 1 g and greater were applied to the
SOD1G93A group, based on the percentage of positive responses
to the filament force (Figure 1D). These results reveal a delayed
tactile response in transgenic mice.
The hot water tail immersion test and the hot plate test were
performed to assess temperature-related nociception. These tests
are complementary. The formermainly evaluates the spinal reflex
arc (König et al., 1996), whereas the latter requires supraspinal
processing (Le Bars et al., 2001). Regarding the hot water
tail immersion test, no significant differences in tail withdraw
latencies were not observed between transgenic and control mice
at 45, 47, and 49◦C. The hot plate test, which evaluates the
latency of a mouse to jump off a warming plate, was performed
with plates at 50 and 52◦C (Figures 1E,F). At both temperatures,
SOD1 transgenic mice exhibited a significantly delayed latency
(mean latency, 47.8 ± 2.53 vs. 65.2 ± 2.46 s at 50◦C, p = 0.0217;
12.04± 0.86 vs. 20.6± 2.34 s at 52◦C, p= 0.0024) (Figures 1E,F).
SN-SGC Units Express Mutant SOD1 at
High Levels in SOD1G93A Mice
The levels of both endogenous mouse SOD1 and mutant
SOD1G93A were estimated by performing Western blotting of
DRG lysates using an antibody that recognizes murine and
human SOD1. As expected, non-significant differences in murine
SOD1 levels were detected in the DRG between control and
SOD1G93A mice. In contrast, high levels of SOD1G93A were
detected in the SOD1G93A DRG (Figure 2A). This finding
confirms the overexpression of the mutant human SOD1 in the
DRG of transgenic SOD1G93A mice and suggests that the high
levels of the mutant human dismutase do not exert a negative
dominant effect on wild-typemurine SOD1 expression. Thus, the
gain of function of the mutant SOD1G93A rather than the loss of
function of the murine SOD1, might be involved in the sensory
dysfunction observed in SOD1G93A mice.
Next, we investigated the subcellular distribution of SOD1
in SN-SGC units (Figure 2B) from control and SOD1G93A mice
by performing immunofluorescence staining using a polyclonal
rabbit anti-SOD1 antibody. At 75 days of age, a very weak
cytoplasmic signal was detected in both neurons and SGCs from
control mice (Figure 2E). Conversely, in SN-SGC units from
the SOD1G93A mice, high SOD1 expression was observed in
SGCs, and to a lesser extent, in sensory neurons (Figures 2F–H).
Moreover, SOD1 expression was markedly increased in the
cytoplasm of SGCs compared with the nucleus (Figures 2F–H).
This observation was confirmed by the densitometry analysis
of the fluorescent intensity of SOD1 in the nucleus and
cytoplasm of SGCs, that revealed significant differences between
these two compartments (Figure 2C). In sensory neurons from
SOD1G93A mice, SOD1 expression was generally increased in
the nucleus compared with the cytoplasm (Figures 2D,H). At
95 days of age, a similar pattern of SOD1 expression was
observed in SN-SGC units from both control and SOD1G93A
mice when compared to their respective 75-day-old control
and SOD1G93A mice (Figures 2I–L). Interestingly, some SGCs
exhibited cytoplasmic SOD1 aggregates in SOD1G93A mice
(Figures 2M–O). Moreover, cytoplasmic aggregation of SOD1
was associated with the accumulation of ubiquitylated proteins
as revealed by immunostaining for ubiquitin-protein conjugates
(Figure 2P). Based on the biochemical determination of the levels
of the SOD1 protein and the reduced expression of this dismutase
in control SN-SGC units, the SOD1 immunofluorescence signal
mainly corresponded to the transgenic expression of the mutant
SOD1 protein.
Overexpression of Mutant SOD1G93A Is
Associated With Nitro-Oxidative Stress and
Biogenesis of Lipid Droplets in SGCs
As an in situ marker of oxidative stress, we assessed lipid
peroxidation levels using the fluorescent probe BODIPY-C11.
The lipid peroxidation signal was clearly increased in dissociated
SN-SGC units from SOD1G93A mice compared with control
animals (Figures 3A,B). Lipid peroxides accumulated in
the cytoplasm of both sensory neurons and SGCs from
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FIGURE 3 | (A–E) In situ determination of lipid peroxidation with the BODIPY-C11 probe in SN-SGC units from control (A) and SOD1G93 mice (B,D,E). (A) In control
SN-SGC units both sensory neurons and SGCs (arrows) exhibit low fluorescent signal of lipid peroxidation in the cytoplasm. (B,D,E) Lipid peroxidation signal intensity
notably increases in the cytoplasm of both sensory neurons and SGCs from SOD1G93 mice, although BODIPY-C11 labeling was substantially higher in SGCs. Note
the absence of fluorescent signal in the nucleus. (C) Densitometric analysis of the cytoplasmic BOBIDY-C11 fluorescent signal intensity in sensory neurons and SGCs
from SOD1G93 mouse at day 75 of age. (F) BODIPY-493/503 staining of a SN-SGC unit from the SOD1G93 mouse at day 75 of age. Spherical lipid droplets of neutral
lipids appear intensity labeled with the probe. Lipid droplets are larger and more abundant in SGCs (arrows) than in the sensory neuron (arrowhead). The limits of the
SGC have been drawn with dashed green lines. (G) Ultrastructural image of the SGC cytoplasm from a SOD1G93A mouse illustrating the presence of numerous
lysosomes with a heterogeneous morphology, isolated cisterns of endoplasmic reticulum (ER), some mitochondria (mi) and a lipid droplet (asterisk). (H) Detail of two
spatially associated lipid droplets (asterisks) in a SGC from the SOD1G93 mouse. (I) Electron micrograph showing very complex lysosomal compartments that includes
large lipid droplets (asterisks). Scale bar: (A,B,F) 10µm; (D,E) 5µm; (G,H) 1µm; (I) 2µm. Student t-test in (C) p < 0.001.
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FIGURE 4 | SGCs from SOD1G93 mice markedly increase the lysosomal compartment. (A,B) Semithin sections of DRG from control (A) and SOD1G93 mice (B)
stained with toluidine blue illustrating the organization of SN-SGC units. Note the accumulation of basophilic granules identified as lysosomes in some SGCs from
SOD1G93 mice (arrows and inset in B). (C) Quantitative analysis of SN-SGC units from control and SOD1G93 mice carrying basophilic granules in the SGC cytoplasm
at 75 and 95 days of age. (D,E) Quantitative analysis of the proportion of types (A–C) SN-SGC units from SOD1G93 mice carrying basophilic granules in the SGC
cytoplasm at 75 (D) and 95 (E) days of age. (F) Representative example of a western blot of cathepsin D expression in DRG from SOD1G93 and wild-type mice.
(Continued)
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FIGURE 4 | Alpha-tubulin was used as loading control. Note the increased expression of cathepsin D in SOD1G93 mice. (G–L) Immunostaining for cathepsin D
counterstained with propidium iodide (PI) of SN-SGC units from control (G–I) and SOD1G93 mouse (J–L). Note the few immunostained lysosomes in control SGCs
and their prominent storage in SGCs from the SOD1G93 mouse (insets). Conversely, there are no appreciable differences in the distribution of lysosomes between the
control and SOD1G93 sensory neurons. Scale bar: (A,B) 10µm; (G–L) 5µm. Student t-test in (C–E) p < 0.001, ***p < 0.001.
SOD1G93A mice and significantly increased levels were
found in the latter (Figure 3B) as evidenced by the results
of comparative analysis of the optical density of the fluorescent
BODIPY-C11 signal (Figure 3C). Moreover, the cytoplasmic
distribution of the BODIPY-C11 signal in SGCs was not
homogeneous, and some cytoplasmic domains exhibited
higher fluorescence intensity (Figures 3D,E), which may reflect
either the formation of SOD1 aggregates or the existence of
clusters of membrane-bound organelles with high levels of
lipid peroxidation.
The cellular stress response of ROS and free radical generation
may induce the formation of lipid droplets that accumulate as
neutral lipid in non-adipocyte cells (Liu et al., 2015). We used the
lipophilic fluorescent probe BODIOY-493/503 to assess whether
mutant SOD1G93A overexpression induced the formation of lipid
droplets. Lipid droplets labeled with this probe were frequently
detected in SGCs from the 75-day-old SOD1G93A mice and to
a lesser extent in sensory neurons but not in samples from
control mice (Figure 3F). The electron microscopy analysis
confirmed the presence of lipid droplets with a variable electron
density in SOD1G93A SN-SGC units, which appeared either as
isolated lipid droplets surrounded by cytoplasmic organelles
(Figures 3G,H, 6F) or formed part of more complex lysosome-
related structures (Figure 3I).
Overexpression of Mutant SOD1G93A
Induces a Lysosomal Storage in SGCs
We stained semithin sections of DRG with toluidine blue and
performed an electron microscopy analysis to determine the
morphological alterations induced by the overexpression of
mutant SOD1G93A in SN-SGC units. In control SN-SGC units,
toluidine blue staining revealed the typical distribution of large
(type A), medium (type B), and small size (type C) SN-SGC
units in the endoneural tissue microenvironment (Figure 4A).
In SOD1G93A mice, the global structural organization of
SN-SGC units was preserved at the presymptomatic stage
(75 days of age). Intriguingly, numerous SGCs, particularly
SGCs from small- and medium-sized units (types B and C),
showed a substantial accumulation of basophilic granules, which
were identified as lysosomes, in extensive areas of cytoplasm
(Figure 4B). Interestingly, when it occurred, the expansion of
the lysosomal compartment was frequently observed in several
SGCs of the same SN-SGC unit. Abnormal lysosomal storage
was rarely observed in SGCs from control DRG (Figure 4A). The
proportion of SN-SGC units exhibiting lysosomal storage defect
in glial cells, which was estimated using toluidine blue-stained
semithin sections, was ∼30 and 33% in SOD1G93A mice at 75
and 95 days of age, respectively (Figure 4C). Specifically, this
proportion was significantly higher in type B and C units than
in larger type A units at both ages (Figures 4D,E).
The lysosomal nature of the basophilic granules was
confirmed in dissociated SN-SGC units immunostained for
the proteolytic enzyme cathepsin D, a lysosomal marker, and
counterstained with propidium iodide. A few cathepsin D-
positive lysosomes were observed in control SGCs, whereas large
clusters of immunostained lysosomes were frequently observed
in SGCs from SOD1G93A mice (Figures 4G–L). Lysosomes were
preferentially distributed in the perinuclear cytoplasm in sensory
neurons from in both control and SOD1G93A mice, but signs of
aberrant lysosomal storage were not detected (Figures 4G–L).
A western blot analysis confirmed the increase in levels of
the cathepsin D protein in DRG lysates from SOD1G93A mice
compared with wild-type animals (Figure 4F).
A low-magnification electron microscopy analysis revealed
the morphological organization of SN-SGC units in the
DRG from control and SOD1G93A mice at 75 days of age
(Supplementary Figures 1A,B). This electron microscopy
examination confirmed the presence of SGCs with a lysosomal
storage defect (Supplementary Figure 1A). At a higher
magnification, the ultrastructural features of SGCs from control
DRG were characterized by a cell nucleus with a peripheral
distribution of heterochromatin and a perinuclear cytoplasm
enriched in mitochondria and Golgi complexes. The cytoplasm
also exhibited some endoplasmic reticulum cisternae and isolated
lysosomes (Figures 5A,B). Moreover, cell bodies and organelle-
poor flat processes of SGCs completely wrapped neuronal
perikaryal as previously reported (Pannese, 1981; Hanani, 2005)
(Figures 5A,B). In contrast, at the presymptomatic stage, SGCs
from the SOD1G93A mice frequently showed an unstructured
perinuclear cytoplasm due to the extensive accumulation of
densely packed electron-dense bodies identified as lysosome-
related structures (Figures 5C,D). Although the lysosomal
storage defect preferentially appeared in SGC bodies, numerous
lysosomes were also distributed in some flattened processes
(Figure 5E). The aberrant accumulation of electron-dense
bodies appears to reflect disrupted lysosomal homeostasis
(cacostasis), which leads to a non-inherited lysosomal storage
pathology in these cells. Abnormal lysosomal storage was
accompanied by reductions in both the number of Golgi
complexes and protein synthesis machinery, particularly free
polyribosomes and ER cisterns (Figures 5C,D).
The storage lysosomes displayed a variety of ultrastructural
morphologies. They included small round primary lysosomes
with a homogeneous texture and larger polymorphic secondary
lysosomes that varied in size or morphology (Figures 5C–E).
Some large and complex structures contained intralysosomal
(i) electron-lucent areas; (ii) domains with a multilamellar
(myelin-like) configuration composed of closely packed lamellae;
and (iii) bodies or particles with a very high electron
density (Figures 5C,F,G). Regarding the latter, the highly
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FIGURE 5 | Lysosomal storage disorder in SGCs from SOD1G93 mouse at presymptomatic stage (75 days of age). (A,B) Ultrastructure of control SGSs surrounding
sensory neurons (SN). Note in the (B) the characteristic organization of cytoplasmic organelles, including the Golgi complex (Go), endoplasmic reticulum,
(Continued)
Frontiers in Aging Neuroscience | www.frontiersin.org 10 November 2020 | Volume 12 | Article 595751
Ruiz-Soto et al. Satellite Glial Cells in ALS
FIGURE 5 | mitochondria, and some scattered lysosomes (Ly). N: nucleus. (C) Panoramic vision of a SGC from a SOD1G93A mouse surrounding three sensory
neurons (SN). Note the prominent storage of lysosome-related structures with an heterogenous morphology. (D,E) Detail of the focal accumulation of lysosomes at
the marginal cytoplasm (D) and in a glial expansion (E) in SGCs from the SOD1G93 mouse. Many secondary lysosomes include electron-lucent areas. (F) High
magnification of characteristic secondary lysosomes and residual bodies (lipofuscin bodies) containing material of diverse nature including electron-lucent areas and
very electron-dense particles (arrows). (G) Detail of the intra-lysosomal organizations of a lamellar myelin-like structure. (H) Lipofuscin autofluorescence of SN-SGC
units from SOD1G93 mouse. Note some lipofuscin granules in the cytoplasm of sensory neurons and the higher autofluorescent signal intensity in the cytoplasm of
SGCs. Scale bar: (A–E) 1µm; (F) 400 nm; (G) 50 nm; (H) 10µm.
electron dense structures may represent focal deposits of iron
or other metals derived from the intralysosomal oxidation
of metalloproteases (Figure 5F). Moreover, some complex
lysosome-related structures containing large electron-lucent
areas may be residual bodies of lipofuscin containing indigestible
oxidized lipids and proteins (Figure 5F). The presence of
residual bodies of lipofuscin was confirmed by their strong
autofluorescence signal detected using confocal microscopy
(Figure 5H), a typical feature of lipofuscin granules (Luzio et al.,
2007). Moreover, a diffuse cytoplasmic pool of lipofuscin was also
observed (Figure 5H).
During the symptomatic stage (95 days of age), the
cytoplasmic accumulation of components of the lysosomal
system was increased, and some SGCs exhibited signs of
advanced cell degeneration, including vacuolar degeneration
of lysosomes and other organelles as well as cytoplasmic
swelling (Figures 6A–I). Intralysosomal highly electron-dense
bodies that were presumably enriched inmetals, autophagosomes
containing heterogeneous cellular structures and lipid droplets
were frequently observed (Figures 6C,E–G). At this symptomatic
stage, the SGC alterations were commonly accompanied by an
increase in the size of lysosomal compartment and occasional
mitochondrial vacuolization in sensory neurons of the SN-
SGC units containing SGCs with a lysosomal storage defect
(Figure 6A). Based on this finding, SGC degeneration may
lead to the metabolic dysfunction of sensory neurons, which
specifically affects lysosomal homeostasis.
DISCUSSION
The present study strengthens the current conception of ALS
as a predominant but not an exclusively motor circumscribed
disease in which other neuronal and non-neuronal systems may
be affected. In our study, the employed behavioral tests mainly
evaluate protopathic manifestations, the stimuli of which are
principally transmitted by type B and C sensory neurons. Thus,
we particularly focused on these neurons and their associated
SGCs in the present study.
Interestingly we observed the presence of subtle sensory
manifestations even before of the appearance of motor
symptomatology. Consistent with findings reported in a
previous study by Vaughan et al. (2015) examining two strains
of transgenic mice harboring SOD1G93A and TARDBPA315T
mutations, the results from the present study suggest that the
degeneration of other non-motor areas might precede and/or
contribute to the MN damage in ALS. Therefore, at the spinal
cord level, complex sensory-motor networks are altered in
patients with ALS (Held et al., 2019). Therefore, some degree
of involvement of the sensory system may easily contribute to
MN damage through different mechanisms, including prion-
like propagation (Prusiner, 2012). Previous studies have reported
disorders at different levels of the sensory pathway including
peripheral receptors, small intraepidermal sensory fibers, sensory
neurons in the DRG, anterolateral and dorsal ascending spinal
tracts and the sensory cortex (Guo et al., 2009; Vaughan et al.,
2015; Rubio et al., 2016; Sassone et al., 2016). However, none
of these studies had previously reported SGCs as potential
disease targets. Based on the increasing importance of neuron-
glia interactions in ALS, the neuron-SGC functional units of
DRG have emerged as a pure system to assess not only the
pathogenic events but also the chronology of the process due to
the particularities of this “functional ecosystem.”
Regarding SOD1 expression in SGCs, our results indicate that
the overexpression of mutant SOD1G93A leads to its intracellular
accumulation in SGCs of the DRG at presymptomatic motor
stages. We propose that the abnormal cytoplasmic accumulation
of mutant SOD1G93A in SGCs is potentially neurotoxic by itself
and may contribute to the dysfunction of SN-SGC units and the
subsequent primary sensory alterations reported here.
In addition to the motor cortex and spinal cord, the abnormal
accumulation of mutant SOD1 has also been reported in other
brain regions, including the temporal cortex, hippocampus, and
cerebellum (Steinacker et al., 2014) as well as DRG neurons in
individuals with ALS (Sábado et al., 2014). Importantly, to the
best of our knowledge, this is the first study suggesting SGCs
as a potential non-motor target in ALS. Several reports have
provided evidence that the accumulation of mutant SOD1 in
MNs from animal models of ALS leads to altered proteostasis
(Riancho et al., 2015). In fact, in SOD1G93A mice, we observed
disruptions in proteostasis accompanied by abnormal SOD1
accumulation, the aggregation of ubiquitylated proteins and
alterations in the autophagy-lysosomal system in SGCs during
the presymptomatic stage. Interestingly, the SOD1G93A mutation
has been reported to destabilize and promote protein misfolding
and its subsequent aggregation (Sibilla and Bertolotti, 2017).
Furthermore mutant SOD1 displays an increased aggregation
propensity compared with the wild-type protein (Prudencio
et al., 2009). The aggregation of the mutant SOD1 protein may be
increased by its ability to propagate its misfolded conformation
by acting as a prion-like protein that escapes protein quality
control and alters the native SOD1 folding process (Münch and
Bertolotti, 2011; Prusiner, 2012; Ayers et al., 2014; Sibilla and
Bertolotti, 2017).
Our results are consistent with the induction of oxidative
stress in SGCs. Aberrant oxidative reactions catalyzed by
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FIGURE 6 | Advanced lysosomal storage disorder in SGCs from SOD1G93 mice at symptomatic stage (95 days of age). (A) Representative example of several SGSs
from a SOD1G93 mouse with lysosomal storage. One of the associated sensory neurons (SN) shows abundance of lysosomes and cytoplasmic vacuolation of
(Continued)
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FIGURE 6 | mitochondria. N: nucleus. (B) Massive storage of densely packed lysosomes and residual bodies in the cytoplasm of a SGC with severe disruption of the
cytoplasmic organization. (C) Storage of lysosomes in a SGC. Note the presence of very electron-dense intralysosomal structures (white arrow) presumably of metal
nature and some mitochondria (mi). (D) A SGC with high accumulation of lysosomes and prominent heterochromatinization at the nuclear periphery. Note the
well-preserved cytoplasmic organization of the associated sensory neuron with a stack of rough endoplasmic reticulum cisterns (ER). (E) Large cytoplasmic area with
high concentration of small rounded and homogenous primary lysosomes, larger and heterogenous secondary lysosomes, and lipid droplets (LD). (F,G) Detail of SGC
cytoplasm showing autophagosomes (arrows) and a lipid droplet (asterisk in F). (H,I) Two progressive stages of vacuolar degeneration in SGCs. Note the complete
disruption of glial cell cytoplasm in (I). Scale bar: (A) 2µm; (B–E), (H,I) 1µm; (F,G) 0.5µm.
mutant SODG93A have been proposed to contribute to increased
oxidative stress and cellular toxicity in ALS (Andrus et al., 2002;
Ilieva et al., 2007; Barber and Shaw, 2010; An et al., 2014). In
this context, the results of our experiment using the BODIPY-C11
probe revealed increased lipid peroxidation in SGCs of the DRG
from SOD1G93A mice. Moreover, lipid peroxidation generates
several highly reactive oxidizing agents, including lipofuscin,
which are capable of damaging macromolecules and cellular
organelles (Höhn and Grune, 2013). Thus, we propose that SGCs
of the DRG are important targets of oxidative stress in individuals
with ALS.
Notably, lipid droplets composed of neutral lipids were
observed in SGCs from the SOD1G93A mice, as evidenced
by the BODIPY-493-503 probe and confirmed with electron
microscopy. In addition to their essential role in energy
storage, growing evidence also links lipid droplets to neuron-glia
metabolic coupling (Pennetta and Welte, 2018). In this context,
the high level of lipid peroxidation reported here might represent
a protective detoxification mechanism for the oxidative stress
in sensory neurons. This protective function is relevant to ALS
because metabolic abnormalities in lipid metabolism and the
lipidome are prevalent in the spinal cord of patients with ALS
and SOD1 mice (Chaves-Filho et al., 2019). Moreover, recent
evidence suggests a metabolic switch from glucose to lipids as
the energy source in SOD1 mouse models of ALS (Schmitt
et al., 2014). If this process also occurred in the DRG from
the SOD1 mice, neurons would likely rely on SGCs to store
excess neutral lipids in droplets as a neuroprotective mechanism
by reducing lipotoxicity (Liu et al., 2015; Chaves-Filho et al.,
2019). Interestingly, we detected some lipid droplets inside
autolysosomes, suggesting a mechanism of lipophagy (Welte and
Gould, 2017). Consistently, Rudnick et al. (2017) observed the
activation of autophagy in MNs during the progression of ALS in
SOD1G93A mice, and we often detected autophagosomes in SGCs
from this mouse model of ALS.
The most prominent cellular change observed in SGCs
from the SOD1G93A mouse model of ALS is the substantial
accumulation of cathepsin D-positive lysosomes and residual
bodies, including lipofuscin granules. This cellular response likely
substantially affects SGC function and preferentially occurs in
types B and C SN-SGC units, consistent with the tactile and
thermal-related nociceptive dysfunctions observed in the sensory
tests. To the best of our knowledge, our study provides the
first observation of the involvement of a lysosomal storage
disorder in ALS pathogenesis. Moreover, altered autophagy-
lysosomal homeostasis appears to be a major subcellular pathway
underlying the toxicity of mutant SOD1G93A toxicity in SGCs.
Importantly, increased lysosomal storage in SGCs occurs at
the presymptomatic stage (75 days of age) in the SOD1G93A
mouse model of ALS, a time prior to the appearance of
detectable cellular alterations in sensory neurons. This finding
supports the hypothesis that SGCs from the DRG are also
primary cellular targets of oxidative stress and proteostasis
disturbances in ALS (Supplementary Figure 2). Moreover, the
dysfunction of the autophagy-lysosomal system was noted in
several SGCs of the same SN-SGC unit, suggesting that the
prion-like nature of the mutant SOD1 protein may potentially
contribute to the propagation of its toxicity through intercellular
communication mechanisms.
We postulate that the pathogenic cascade that leads to
excessive storage of lysosomes in SGC is triggered by oxidative
stress induced by the abnormal accumulation and toxicity of the
mutant SOD1G93A protein. Regarding the potential defects in
the activity of lysosomal enzymes in SGCs, aberrant changes in
glucosylceramide, galactolipids, and sphingomyelin levels have
been reported in the spinal cord of patients with ALS and SOD1
mouse models of the disease (Dodge et al., 2015).
The lysosomal storage disorder in SGCs appears to reflect a
severe disturbance of proteostasis that particularly affects cellular
mechanisms of macromolecular degradation. In this context,
dysfunction of both the ubiquitin proteasome and autophagy-
lysosomal systems has been reported in the spinal cord of
patients with ALS and SOD1G93A mice (Rudnick et al., 2017).
Consistent with this observation, we observed an abundance of
autophagosomes in SGCs from this mouse model of ALS.
CONCLUSIONS
Our study strengthens the current widely accepted concept of
ALS as a non-MN exclusively circumscribed disorder, supporting
the sensory involvement noted in the SOD1 transgenic murine
model of the disease. Specifically, we first highlighted SGCs as a
new potential target for the disease (Supplementary Figure 2).
The preferential lysosomal pathology observed in these cells
meets the criteria for a lysosomal storage disorder induced
by oxidative stress (Kielian, 2019; Marques and Saftig, 2019).
Moreover, SGCs appear to have an essential function in
maintaining sensory neurons homeostasis, thus reinforcing the
crucial role of astroglial cells in ALS (Baker et al., 2015). Based
on both the existence of sensory-motor networks in the spinal
cord and the prion hypothesis, SGCs might be responsible for
the sensory manifestations and potentiate or propagate motor
neuron pathology. The inclusion of these “new guests” into ALS
pathogenesis will provide new pathogenic perspectives thatmight
result in the development novel therapeutic strategies.
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